DR. JEREMY SCOTT NORWOOD M.D.
Prescription History 1801010921
Urology in Shreveport, LA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JEREMY SCOTT NORWOOD M.D., an active Urology specialist practicing in Shreveport, LA. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,113 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 437 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other LA PrescribersVs. LA Avg |
|---|---|---|---|
| Tamsulosin Hcl | 437 | $17.77 | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 437 Medicare prescriptions for Tamsulosin Hcl, about 4.6 times the volume of the typical Louisiana prescriber of this medication (96). Medicare paid an average of $17.77 per fill, versus $14.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,272.1 30-Day Fills standardized to 30-day supplies 38,010 Days of Medication total across all patients in 2023 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 139 | $4.10▼ below LA avg | ≈ Typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 139 Medicare prescriptions for Hydrocodone-Acetaminophen, about 1.2 times the volume of the typical Louisiana prescriber of this medication (114). Medicare paid an average of $4.10 per fill, versus $17.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 139 30-Day Fills standardized to 30-day supplies 409 Days of Medication total across all patients in 2023 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 88 | $38.27 | ▲ More than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2023, this provider wrote 88 Medicare prescriptions for Nitrofurantoin Mono-Macro, about 3.1 times the volume of the typical Louisiana prescriber of this medication (28). Medicare paid an average of $38.27 per fill, versus $25.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 100 30-Day Fills standardized to 30-day supplies 1,619 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 82 | $13.93▼ below LA avg | ▲ More than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 82 Medicare prescriptions for Doxycycline Hyclate, about 2.5 times the volume of the typical Louisiana prescriber of this medication (33). Medicare paid an average of $13.93 per fill, versus $18.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 84 30-Day Fills standardized to 30-day supplies 1,004 Days of Medication total across all patients in 2023 | |||
| Finasteride | 72 | $16.37 | ≈ Typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2023, this provider wrote 72 Medicare prescriptions for Finasteride, about 1.2 times the volume of the typical Louisiana prescriber of this medication (61). Medicare paid an average of $16.37 per fill, versus $14.04 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 193.3 30-Day Fills standardized to 30-day supplies 5,777 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 67 | $894.69 | ≈ Typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 67 Medicare prescriptions for Myrbetriq, about 1.2 times the volume of the typical Louisiana prescriber of this medication (54). Medicare paid an average of $894.69 per fill, versus $558.80 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 129 30-Day Fills standardized to 30-day supplies 3,870 Days of Medication total across all patients in 2023 | |||
| Testosterone Cypionate | 52 | $24.47▼ below LA avg | ▲ More than typical |
About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾ In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women. In 2023, this provider wrote 52 Medicare prescriptions for Testosterone Cypionate, about 1.7 times the volume of the typical Louisiana prescriber of this medication (30). Medicare paid an average of $24.47 per fill, versus $45.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 63.6 30-Day Fills standardized to 30-day supplies 1,815 Days of Medication total across all patients in 2023 | |||
| Levofloxacin | 29 | $9.10 | ≈ Typical |
About Levofloxacin: This medication is used to treat a variety of bacterial infections. Show more ▾ Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2023, this provider wrote 29 Medicare prescriptions for Levofloxacin, about the same volume as the typical Louisiana prescriber of this medication (27). Medicare paid an average of $9.10 per fill, versus $8.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 398 Days of Medication total across all patients in 2023 | |||
| Estradiol | 28 | $104.24 | ▼ Less than typical |
About Estradiol: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 28 Medicare prescriptions for Estradiol, about 65% of the volume of the typical Louisiana prescriber of this medication (43). Medicare paid an average of $104.24 per fill, versus $45.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 68.3 30-Day Fills standardized to 30-day supplies 2,050 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $11.70 | ≈ Typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 27 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about the same volume as the typical Louisiana prescriber of this medication (27). Medicare paid an average of $11.70 per fill, versus $5.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 425 Days of Medication total across all patients in 2023 | |||
| GemtesaVibegron | 26 | $1,015.81 | ≈ Typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. In 2023, this provider wrote 26 Medicare prescriptions for Gemtesa, about 76% of the volume of the typical Louisiana prescriber of this medication (34). Medicare paid an average of $1,015.81 per fill, versus $510.17 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 54.3 30-Day Fills standardized to 30-day supplies 1,630 Days of Medication total across all patients in 2023 | |||
| ErleadaApalutamide | 19 | $15,214.67 | ≈ Typical |
About Erleada: Apalutamide is used to treat men with prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. In 2023, this provider wrote 19 Medicare prescriptions for Erleada, about the same volume as the typical Louisiana prescriber of this medication (21). Medicare paid an average of $15,214.67 per fill, versus $14,752.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
| Fluconazole | 19 | $5.92▼ below LA avg | ▼ Less than typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2023, this provider wrote 19 Medicare prescriptions for Fluconazole, about 73% of the volume of the typical Louisiana prescriber of this medication (26). Medicare paid an average of $5.92 per fill, versus $11.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 19 30-Day Fills standardized to 30-day supplies 57 Days of Medication total across all patients in 2023 | |||
| OrgovyxRelugolix | 16 | $2,781.71 | ▼ Less than typical |
About Orgovyx: Relugolix is used to treat prostate cancer in men. Show more ▾ It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Relugolix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells. In 2023, this provider wrote 16 Medicare prescriptions for Orgovyx, about half the volume of the typical Louisiana prescriber of this medication (34). Medicare paid an average of $2,781.71 per fill, versus $2,626.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2023 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $13.91 | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate. In 2023, this provider wrote 12 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about half the volume of the typical Louisiana prescriber of this medication (26). Medicare paid an average of $13.91 per fill, versus $12.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 142 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. JEREMY SCOTT NORWOOD M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Urology prescribing approach at this Shreveport, LA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among LA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
